These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects. Manji HK; Hsiao JK; Risby ED; Oliver J; Rudorfer MV; Potter WZ Arch Gen Psychiatry; 1991 Jun; 48(6):505-12. PubMed ID: 1645513 [TBL] [Abstract][Full Text] [Related]
29. Clomipramine enhances prolactin and growth hormone responses to L-tryptophan. Anderson IM; Cowen PJ Psychopharmacology (Berl); 1986; 89(1):131-3. PubMed ID: 3016787 [TBL] [Abstract][Full Text] [Related]
30. [The clomipramine test and subtypes of depression]. González-Pinto A; López Ibor JJ; Sáiz J; Gutiérrez M; Figuerido JL; García Godoy MJ Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):303-9. PubMed ID: 9054201 [TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial. Yamada K; Yagi G; Kanba S Psychiatry Clin Neurosci; 2003 Apr; 57(2):183-7. PubMed ID: 12667165 [TBL] [Abstract][Full Text] [Related]
32. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects. Ruegg RG; Gilmore J; Ekstrom RD; Corrigan M; Knight B; Tancer M; Leatherman ME; Carson SW; Golden RN Biol Psychiatry; 1997 Dec; 42(12):1123-9. PubMed ID: 9426882 [TBL] [Abstract][Full Text] [Related]
33. Study of the clomipramine-morphine interaction in the forced swimming test in mice. Eschalier A; Fialip J; Varoquaux O; Makambila MC Psychopharmacology (Berl); 1987; 93(4):515-9. PubMed ID: 3124185 [TBL] [Abstract][Full Text] [Related]
34. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. Benkelfat C; Murphy DL; Zohar J; Hill JL; Grover G; Insel TR Arch Gen Psychiatry; 1989 Jan; 46(1):23-8. PubMed ID: 2910220 [TBL] [Abstract][Full Text] [Related]
35. Clomipramine-induced sleep disturbance does not impair its prolactin-releasing action. Follenius M; Spiegel K; Gronfier C; Saini J; Brandenberger G J Endocrinol Invest; 1994 Jun; 17(6):417-23. PubMed ID: 7930386 [TBL] [Abstract][Full Text] [Related]
36. The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Attar-Lévy D; Martinot JL; Blin J; Dao-Castellana MH; Crouzel C; Mazoyer B; Poirier MF; Bourdel MC; Aymard N; Syrota A; Féline A Biol Psychiatry; 1999 Jan; 45(2):180-6. PubMed ID: 9951565 [TBL] [Abstract][Full Text] [Related]
37. Central 5-HT receptor hypersensitivity in migraine without aura. Cassidy EM; Tomkins E; Dinan T; Hardiman O; O'Keane V Cephalalgia; 2003 Feb; 23(1):29-34. PubMed ID: 12534577 [TBL] [Abstract][Full Text] [Related]
38. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers. Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270 [TBL] [Abstract][Full Text] [Related]
39. Differential effect of clomipramine treatment on m-chlorophenylpiperazine-induced increases in plasma prolactin and corticosterone in rats. Wozniak KM; Aulakh CS; Hill JL; Murphy DL Pharmacol Biochem Behav; 1989 May; 33(1):265-7. PubMed ID: 2780783 [TBL] [Abstract][Full Text] [Related]